These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6714625)

  • 1. [Prevention of the nonhemolytic type of reactions during the transfusion of blood and its components].
    Zaĭtseva GA; Zheleznova AI; Moiseeva VG; Aribzhanova IM; Vozgegova NP
    Gematol Transfuziol; 1984 Mar; 29(3):24-7. PubMed ID: 6714625
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention of HLA sensibilization].
    Timoshenko LI; Baĭ EN; Babiĭ ZN; Burka NI; Krishtof AN
    Vrach Delo; 1982; (10):52-4. PubMed ID: 7179881
    [No Abstract]   [Full Text] [Related]  

  • 3. A study of platelet alloantibody in multiply-transfused haematology patients.
    Linn YC; Prakash P; Ong YW
    Ann Acad Med Singap; 1995 Mar; 24(2):305-11. PubMed ID: 7653976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunologic aspects of thrombocyte transfusion].
    Mueller-Eckhardt C
    Beitr Infusionsther; 1991; 28():132-41. PubMed ID: 1725611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gamma radiation does not prevent transfusion-induced HLA alloimmunization.
    Ohto H
    Transfusion; 1997 Aug; 37(8):878-9. PubMed ID: 9280338
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunologic factors in reactions to blood transfusions.
    McLeod BC
    Heart Lung; 1980; 9(4):675-81. PubMed ID: 6773907
    [No Abstract]   [Full Text] [Related]  

  • 7. [Platelet and granulocyte transfusion in hematology].
    Ouellet P
    Union Med Can; 1983 May; 112(5):457-60. PubMed ID: 6879858
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prevention of HLA-alloimmunization of recipients of platelet concentrates].
    Kuntz BM; Wollenhaupt HJ; Brüster HT
    Beitr Infusionsther; 1991; 28():209-12. PubMed ID: 1725621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The phenomenon of the enhancement of the formation of lymphocytotoxic alloimmune antibodies during the use of plasmapheresis].
    Zotikov EA; Babaeva AG; Kalinin NN; Vasil'eva MN; Golovkina LL; Shtyreva EM; Mikhaĭlova EA; Biriukova LS
    Biull Eksp Biol Med; 1993 Jul; 116(7):61-3. PubMed ID: 8400187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood component therapy in bone marrow transplantation.
    Brand A; Claas FH; Falkenburg JH; van Rood JJ; Eernisse JG
    Semin Hematol; 1984 Apr; 21(2):141-55. PubMed ID: 6330905
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunologic risks of blood transfusion and public health].
    Rouger P; Hergon E; Le Pennec PY; Garnerin P; Valleron AJ
    Transfus Clin Biol; 1994; 1(2):141-53. PubMed ID: 8019649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunologic risk analysis of blood transfusion: 1991-1998].
    Rouger P; Le Pennec PY; Noizat-Pirenne F
    Transfus Clin Biol; 2000 Feb; 7(1):9-14. PubMed ID: 10730341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An investigation of nonhemolytic transfusion reactions.
    Decary F; Ferner P; Giavedoni L; Hartman A; Howie R; Kalovsky E; Laschinger C; Malette M; Martyres A; Mervart H
    Vox Sang; 1984; 46(5):277-85. PubMed ID: 6610251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thrombomatch--an ELISA test for detection of antibodies to HLA antigens and platelet-specific antigens. Clinical experiences in compatibility testing of platelet transfusions].
    Barz D; Gatzka E; Kollmorgen I
    Beitr Infusionsther Transfusionsmed; 1996; 33():47-54. PubMed ID: 8974708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-specific antibodies in transfused patients.
    Uhrynowska M; Zupańska B
    Eur J Haematol; 1996 Apr; 56(4):248-51. PubMed ID: 8641394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfusion problems associated with transplantation.
    Storb R; Weiden PL
    Semin Hematol; 1981 Apr; 18(2):163-76. PubMed ID: 7013074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of severe thrombocytopenia in alloimmunized, transfusion-refractory patients.
    Ornstein DL; Mortara KL; Smith MB; Ririe DW; Shaughnessy PJ; Bickford DJ; Kissack BL
    Mil Med; 2001 Mar; 166(3):269-74. PubMed ID: 11263033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunology of posttransfusion complications].
    Shabalin VN; Serova LD
    Vestn Khir Im I I Grek; 1982 Oct; 129(10):89-94. PubMed ID: 7179672
    [No Abstract]   [Full Text] [Related]  

  • 19. PAS-C platelets contain less plasma protein, lower anti-A and anti-B titers, and decreased HLA antibody specificities compared to plasma platelets.
    Weisberg SP; Shaz BH; Tumer G; Silliman CC; Kelher MR; Cohn CS
    Transfusion; 2018 Apr; 58(4):891-895. PubMed ID: 29473178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gaps in Research on Adverse Events to Transfusion in Pediatrics.
    Jackups R; Savage W
    Transfus Med Rev; 2016 Oct; 30(4):209-12. PubMed ID: 27488141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.